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ABSTRACT
Objectives To prospectively assess the diagnostic
performance of simple ultrasound rules to predict
benignity/malignancy in an adnexal mass and to test the
performance of the risk of malignancy index, two logistic
regression models, and subjective assessment of
ultrasonic findings by an experienced ultrasound
examiner in adnexal masses for which the simple rules
yield an inconclusive result.
Design Prospective temporal and external validation of
simple ultrasound rules to distinguish benign from
malignant adnexal masses. The rules comprised five
ultrasonic features (including shape, size, solidity, and
results of colour Doppler examination) to predict a
malignant tumour (M features) and five to predict a benign
tumour (B features). If one ormoreM featureswere present
in the absence of a B feature, the mass was classified as
malignant. If one or more B features were present in the
absence of anM feature, it was classified as benign. If both
M features and B features were present, or if none of the
features was present, the simple rules were inconclusive.
Setting 19 ultrasound centres in eight countries.
Participants 1938 women with an adnexal mass
examined with ultrasound by the principal investigator at
each centre with a standardised research protocol.
Reference standard Histological classification of the
excised adnexal mass as benign or malignant.
Main outcome measures Diagnostic sensitivity and
specificity.
ResultsOf the 1938 patients with an adnexal mass, 1396
(72%) had benign tumours, 373 (19.2%) had primary
invasive tumours, 111 (5.7%) had borderline malignant
tumours, and 58 (3%) had metastatic tumours in the
ovary. The simple rules yielded a conclusive result in
1501 (77%) masses, for which they resulted in a
sensitivity of 92% (95% confidence interval 89% to 94%)
and a specificity of 96% (94% to 97%). The corresponding
sensitivity and specificity of subjective assessment were
91% (88% to 94%) and 96% (94% to 97%). In the 357
masses for which the simple rules yielded an inconclusive
result and with available results of CA-125
measurements, the sensitivities were 89% (83% to 93%)
for subjective assessment, 50% (42% to 58%) for the risk
of malignancy index, 89% (83% to 93%) for logistic
regression model 1, and 82% (75% to 87%) for logistic
regression model 2; the corresponding specificities were
78% (72% to 83%), 84% (78% to 88%), 44% (38% to
51%), and 48% (42% to55%). Use of the simple rules as a
triage test and subjective assessment for those masses
for which the simple rules yielded an inconclusive result
gave a sensitivity of 91% (88% to93%) anda specificity of
93% (91% to 94%), compared with a sensitivity of 90%
(88% to 93%) and a specificity of 93% (91% to 94%)
when subjective assessment was used in all masses.
Conclusions The use of the simple rules has the potential
to improve the management of women with adnexal
masses. In adnexal masses for which the rules yielded an
inconclusive result, subjective assessment of ultrasonic
findings by an experienced ultrasound examiner was the
most accurate diagnostic test; the risk of malignancy
index and the two regression models were not useful.
INTRODUCTION
Whendeciding on the type of surgery for a patient with
an adnexal mass, estimating the risk of malignancy is
essential. Benign masses can be managed conserva-
tively or with laparoscopy, avoiding unnecessary
costs andmorbidity.On the other hand, peri-operative
rupture of a stage I ovarian cancer may worsen the
prognosis.1 When malignancy is suspected, referral to
a gynaecological oncologist is needed for proper sta-
ging and debulking surgery.
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Transvaginal ultrasonography is an excellent tool
for discriminating between benign and malignant
adnexal masses. Several studies have shown that the
risk of malignancy is very low in unilocular ovarian
cysts.2-5 The presence of morphological features other
than a unilocular cyst, such as papillary structures and
solid areas, as well as increased vascularity as deter-
mined byDoppler ultrasound, is associatedwith a vari-
ably increased risk of malignancy.2 5 Optimisation of
the diagnostic performance of transvaginal sonogra-
phy by creating predictive models with the use of scor-
ing systems, logistic regression analysis, neural
networks, and support vector machines has been
attempted. However, when these models were tested
prospectively, they performed less well than was ori-
ginally reported.6-11 The risk ofmalignancy index is the
test recommended by the Royal College of Obstetri-
cians and Gynaecologists and in a recent review by
Geomini et al.11 12 On the other hand, two logistic
regression models (logistic regression model 1 and
logistic regression model 2) developed in the Inter-
national Ovarian Tumour Analysis (IOTA) study per-
formed as well in new centres as in the units where the
models were first developed,13 but no model or bio-
chemical marker of ovarian malignancy has been
shown to be superior to subjective assessment of grey
scale and colour Doppler ultrasonic findings by an
experienced ultrasound examiner.8 14 15 Unfortunately,
the expertise of experienced ultrasound examiners is
not easily transferred to less experienced examiners.
Less experienced examiners might be helped by scor-
ing systems and risk calculationmodels, but a criticism
has been that the ultrasonic information required in
some ultrasound based risk calculation models is too
difficult to obtain outside specialist centres.16
In a previous report, we used data collected in the
first phase of the IOTA study to develop simple and
clinically useful ultrasound based rules for discriminat-
ing between benign and malignant adnexal masses.5
We developed simple rules and then temporally vali-
dated them prospectively in a small group of patients
(n=507). On temporal validation, the simple rules
yielded a conclusive result in 76% of all tumours, for
which they resulted in a sensitivity with regard to
malignancy of 95%, a specificity of 91%, a positive like-
lihood ratio of 10.5 and negative likelihood ratio of
0.06.5 We concluded that “most adnexal tumours in
an ordinary tumour population can be correctly classi-
fied as benign or malignant using simple ultrasound-
based rules. For tumours that cannot be classified
using simple rules, ultrasound examination by an
expert examiner might be useful.”5
The aim of the study reported here was to do a pro-
spective temporal and external validation in a large
study population to assess the ability of the previously
published simple ultrasound based rules to distinguish
between benign and malignant adnexal masses before
surgery. A secondary aim was to determine the diag-
nostic performance of subjective assessment of ultraso-
nic findings by an experienced ultrasound examiner,
the risk of malignancy index,12 and the logistic regres-
sion models 1 and 2 when used in tumours for which
the simple rules yield an inconclusive result.
METHODS
In this prospective study, the IOTA phase 2 study, we
examined the performance of the simple rules in a
population of women who had surgery for an adnexal
mass. Local clinicians made the decision to operate on
the basis of local rules and clinical judgment. We fol-
lowed the guidelines of the standards for the reporting
of diagnostic accuracy studies initiative.17
Recruitment centres
We tested the rules both in the same seven centres
where they had been developed (old centres5 18) and
in a further 12 centres that had not participated in any
IOTA study before (new centres). In total, 19 centres
from eight countries participated.
Patients
We included patients who presented with at least one
adnexal mass and who had an ultrasound examination
by a principal investigator at one of the participating
centres. In the case of bilateral adnexal masses, we
included the mass with the most complex ultrasonic
morphology in our statistical analysis. If both masses
had similar ultrasonic morphology, we included the
largest one or the one most easily accessible by trans-
vaginal ultrasound. We excluded patients who were
pregnant or refused transvaginal ultrasonography
and those who did not have surgical removal of the
masswithin 120days after the ultrasound examination.
Data collection
A dedicated, secure data collection system was devel-
oped for the study (IOTA 2 study screen, astraia,
Table 1 | Predictive value of each ultrasonic feature used in simple rules among masses for
which simple rules yielded conclusive result (benign or malignant). Values are percentages
(95% confidence interval); numbers
Ultrasonic features Predictive value
For predicting a malignant tumour (M features)
M1—Irregular solid tumour 96 (88 to 98); 64/67
M2—Presence of ascites 97 (93 to 99); 157/162
M3—At least four papillary structures 88 (80 to 93); 75/85
M4—Irregular multilocular solid tumour with largest diameter ≥100 mm 84 (77 to 90); 103/122
M5—Very strong blood flow (colour score 4) 88 (82 to 92); 131/149
At least one M feature 87 (84 to 90); 340/389
For predicting a benign tumour (B features)
B1—Unilocular 99 (98 to 99); 673/681
B2—Presence of solid components, of which largest solid component has
largest diameter <7 mm
100 (90 to 100); 33/33
B3—Presence of acoustic shadows 95 (92 to 97); 223/234
B4—Smooth multilocular tumour with largest diameter <100 mm 99 (97 to 100); 190/191
B5—No blood flow (colour score 1) 98 (96 to 99); 615/629
At least one B feature 97 (96 to 98); 1083/1112
Rule 1: If one or more M features are present in absence of B feature, mass is classified as malignant.
Rule 2: If one or more B features are present in absence of M feature, mass is classified as benign.
Rule 3: If both M features and B features are present, or if no B or M features are present, result is inconclusive
and second stage test is recommended.
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Munich, Germany). A unique identifier was generated
automatically for each patient’s record. Clinicians at
each centre could viewor update only patients’ records
from their own centre.We ensured data security by not
transferring the patient’s name and by encrypting all
data communication. Data integrity and completeness
were ensured by client side checks in the astraia system
and manual checks by one biostatistician and two
expert ultrasound examiners.
Clinical variables
A standardised history was taken in the samemanner as
in the IOTAphase 1 study.18 It included information on
personal history of ovarian cancer and breast cancer;
the number of first degree relatives with ovarian cancer
or breast cancer; and the patient’s age, menopausal sta-
tus, and current hormone treatment. Women aged
50 years or more who had undergone hysterectomy
before menopause were defined as postmenopausal.
Ultrasound examination
In all cases, a principal investigator at the participating
centres did a transvaginal ultrasound scan in the same
standardised manner as in the IOTA phase 1 study.18
The principal investigators were fully trained gynae-
cologists or radiologists with a special interest in gynae-
cological ultrasound and more than five years’
experience in this field. They used a variety of ultra-
sound machines with transvaginal probe frequencies
ranging between 5 and 12 MHz. The investigators
also used transabdominal ultrasonography to examine
large masses that could not be seen in their entirety by
using a transvaginal probe. They used grey scale and
colour Doppler ultrasound images to obtain
morphological and blood flow variables to character-
ise each adnexal mass. Details of the ultrasound exam-
ination technique and the ultrasound terms and
definitions used have been described elsewhere.18 19
Finally, the investigator stated whether the mass was
likely to be malignant or benign on the basis of subjec-
tive evaluation of ultrasonic findings (“subjective
assessment”). The ultrasonic informationwas recorded
prospectively and locked at the time of the examina-
tion and so could not be changed after surgery. We
calculated the risk of malignancy by using the IOTA
logistic regression models 1 and 2 centrally after the
conclusion of the study, ensuring that these logistic
regression models had no role in the decision making
process. The same was true of the simple rules.
Reference standard
The reference standard was the histological diagnosis
and, in case of malignancy, the surgical stage. Surgery
was carried out by laparoscopy or laparotomy, accord-
ing to the surgeon’s judgment. The excised tissues
were examined histologically at the local centre. The
pathologists had no knowledge of the ultrasound
results. We classified tumours according to the criteria
recommended by the International Federation of
Gynaecology and Obstetrics.20
Simple rules
Weapplied to the tumours the simpleultrasoundbased
rules that have been described in detail in a previous
report.5 Briefly, we used five ultrasonic features to pre-
dict a malignant tumour (M features): irregular solid
tumour (M1), ascites (M2), at least four papillary struc-
tures (M3), irregular multilocular solid tumour with a
Benign (n=49)Malignant (n=340)
All patients (n=1970)
Simple rules (n=1938)
Benign (n=1083)Malignant (n=29)
Benign (n=53)Malignant (n=154) Benign (n=211)Malignant (n=19)
Diagnosis
benign (n=230)
Diagnosis
malignant (n=207)
Diagnosis malignant (n=389) Diagnosis benign (n=1112) Result inconclusive (n=437)
Histology (n=389) Histology (n=1112) Experienced ultrasound examiner (n=437)
Histology (n=207) Histology (n=230)
Excluded (n=32):
  No surgical removal of mass within 120 days after ultrasound (n=15)
  Pregnancy at time of examination (n=12)
  Errors in data entry (n=4)
  Protocol violation (n=1)
Flow diagram of simple rules as triage test and subjective assessment by experienced ultrasound examiner as second stage
test
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largest diameter of at least 100mm (M4), and very high
colour content on colour Doppler examination (M5).
We used five ultrasonic features to predict a benign
tumour (B features): unilocular cyst (B1), presence of
solid components for which the largest solid compo-
nent is <7 mm in largest diameter (B2), acoustic sha-
dows (B3), smooth multilocular tumour (B4), and no
detectable blood flow on Doppler examination (B5).
If one or more M features were present in the absence
of a B feature, we classified the mass as malignant (rule
1). If one or more B features were present in the
absence of an M feature, we classified the mass as
benign (rule 2). If both M features and B features
were present, or if none of the features was present,
the simple rules were inconclusive (rule 3).
Logistic regression models 1 and 2
The logistic regressionmodel 1was based on the age of
the patient (in years), the presence of ascites, the pre-
sence of blood flow within a papillary projection, the
largest diameter of the solid component (in milli-
metres, but with no increase >50 mm), the presence
of irregular internal cyst walls, the presence of acoustic
shadows, personal history of ovarian cancer, current
hormonal treatment, the largest diameter of the lesion
(mm), tenderness of the lesion during the examination,
the presence of a purely solid tumour, and the colour
score (1, 2, 3, or 4). The simpler logistic regression
model (model 2) used only the first six variables. As
suggested in the original publication, an estimated
probability of malignancy above 0.10 by logistic
regression model 1 or 2 classified the mass as
malignant.18
Risk of malignancy index
We determined the risk of malignancy index by using
the ultrasonic findings, the menopausal status, and the
serumCA 125 concentration.12We assessed five ultra-
sonic features suggestive of cancer in an ultrasound
score (U): multilocularity, solid areas, bilateral masses,
ascites, and evidence ofmetastases.Uwas 0when none
of these features was present, 1 if one feature was pre-
sent, and 3 if two or more features were present. We
assigned a score (M)of 1 to premenopausalwomenand
a score of 3 to postmenopausalwomen.Wedefined the
risk of malignancy index as U×M×serumCA 125 con-
centration (U/mL). As suggested in the original publi-
cation, a risk of malignancy index of more than 200
classified the mass as malignant.12
Statistical analysis
We compared the simple rules with subjective assess-
ment by an experienced ultrasound examiner, the risk
of malignancy index, and the logistic regression mod-
els 1 and 2 in cases in which the simple rules yielded a
conclusive result.We also assessed the performance of
a strategy in which the simple rules were used as a
triage test,21 with a second stage test (subjective assess-
ment, risk of malignancy index, or logistic regression
model 1 or 2) being used for masses for which the sim-
ple rules yielded an inconclusive result.
We expressed diagnostic performance in terms of
sensitivity and specificity. We used Wilson’s method
to calculate the 95% confidence limits of binomial pro-
portions.We usedMcNemar’s test to determine the sta-
tistical significance of differences in paired binomial
proportions: sensitivity and specificity. We determined
the statistical significance of differences in categorical
data for unpaired comparisons by using the χ² test. We
used SAS system release 9.2 for statistical analyses.
RESULTS
We enrolled 1970 patients between November 2005
and October 2007. Of these, we excluded 32 (1.6%)
for the following reasons: no surgical removal of the
mass within 120 days after the ultrasound examination
(n=15), pregnant at the time of the examination (n=12),
Table 2 | Sensitivity and specificity of simple rules, subjective
assessment, logistic regression models 1 and 2, and risk of
malignancy index in cases in which simple rules yielded
conclusive result (benign or malignant), stratified by
menopausal status
Sensitivity
(95% CI)
Specificity
(95% CI)
All cases
Total (n=1501):
Simple rules 92 (89 to 94) 96 (94 to 97)
Subjective assessment 91 (88 to 94) 96 (94 to 97)
Logistic regression model 1 94 (91 to 96) 92 (91 to 94)
Logistic regression model 2 95 (92 to 97) 91 (89 to 92)
Premenopausal (n=969):
Simple rules 91 (84 to 95) 97 (95 to 98)
Subjective assessment 90 (83 to 94) 97 (96 to 98)
Logistic regression model 1 90 (83 to 94) 96 (94 to 97)
Logistic regression model 2 92 (85 to 96) 95 (93 to 96)
Postmenopausal (n=532):
Simple rules 93 (89 to 95) 92 (89 to 95)
Subjective assessment 91 (87 to 94) 90 (86 to 93)
Logistic regression model 1 96 (93 to 98) 83 (78 to 87)
Logistic regression model 2 97 (93 to 98) 77 (72 to 82)
Cases with CA 125 available
Total (n=1147):
Simple rules 92 (89 to 95) 95 (93 to 96)
Subjective assessment 91 (87 to 93) 95 (93 to 96)
Logistic regression model 1 94 (91 to 96) 91 (89 to 93)
Logistic regression model 2 95 (93 to 97) 89 (87 to 91)
Risk of malignancy index 75 (71 to 80) 95 (93 to 96)
Premenopausal (n=688):
Simple rules 91 (84 to 95) 96 (94 to 98)
Subjective assessment 90 (83 to 95) 97 (95 to 98)
Logistic regression model 1 90 (83 to 95) 94 (92 to 96)
Logistic regression model 2 92 (85 to 96) 94 (92 to 96)
Risk of malignancy index 55 (45 to 64) 96 (94 to 97)
Postmenopausal (n=459):
Simple rules 93 (88 to 95) 92 (87 to 95)
Subjective assessment 91 (87 to 94) 90 (86 to 94)
Logistic regression model 1 96 (93 to 98) 81 (76 to 86)
Logistic regression model 2 97 (94 to 98) 78 (72 to 83)
Risk of malignancy index 84 (79 to 88) 91 (87 to 94)
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errors in data entry (n=4), and protocol violation (n=1)
(figure). We thus included data from 1938 patients.
The mean age was 46 (range 11-94) years, 38% (742)
of the patients were postmenopausal, 41% (793) were
nulliparous, and 11% (214) were receiving hormonal
treatment. Of the tumours, 542 (28%) were malignant,
including 111 (20%) borderline masses, 373 (69%) pri-
mary invasivemasses, and 58 (11%)metastaticmasses.
Table 1 shows thepredictive value of eachultrasonic
feature used in the simple rules. In total, the simple
rules yielded a conclusive result (rule 1=malignant,
rule 2=benign) for 1501 of the tumours. This corre-
sponds to 77% (1501) of all masses in the dataset. The
malignancy rate was 25% (369/1501) in masses for
which the simple rules yielded a conclusive result,
compared with 40% (173/437) in the remainder
(P<0.001). In 456 cases at least one feature for a malig-
nant tumour (M feature) was present, and in 389 (85%)
of these no B feature was present. Of the 389 masses
predicted to be malignant by the simple rules, 87%
(340) were malignant according to histology. In 1179
cases at least one B feature was present, and in 1112
(94%) of these no M features were present. Of the
1112 masses predicted to be benign by the simple
rules, 97% (1083) were benign according to histology.
Among the tumours for which the simple rules
yielded a conclusive result, they had a sensitivity of
92% (340/369) and a specificity of 96% (1083/1132)
(table 2). Among these tumours, the sensitivity and
specificity of subjective assessment were similar to
those of the simple rules: 91% (336/369) (P=0.35) and
96% (1083/1132) (P=1.0). Subjective assessment
missed 33 cancers (false negative) and gave 49 false
positive diagnoses. The simple rules missed 29 cancers
and gave 49 false positive diagnoses. The simple rules
performed similarly in “old” and “new” centres: the
sensitivity was 93% (179/192) in the old centres and
91% (161/177) in the new centres (P=0.42), and the
specificity was 95% (487/513) in the old centres and
96% (596/619) in the new centres (P=0.27). The sensi-
tivity of the simple rules was similar in premenopausal
and postmenopausal patients (91% (102/112) v 93%
(238/257); P=0.62) but the specificity was higher in
the premenopausal patients (97% (829/857) v 92%
(254/275); P=0.004). The simple rules yielded a con-
clusive result more often in premenopausal patients
than in postmenopausal patients (81% (969/1196) v
72% (532/742); P<0.001).
Table 3 shows the diagnostic performance of sub-
jective assessment, logistic regression models 1 and 2,
and the risk of malignancy index among the tumours
for which the simple rules yielded an inconclusive
result (rule 3). Among these tumours, the diagnostic
performance of subjective assessment by the ultra-
sound examiner was superior to that of logistic regres-
sion model 1, logistic regression model 2, and the risk
of malignancy index in both premenopausal and post-
menopausal patients. Logistic regression model 1 and
logistic regressionmodel 2 had low specificity,whereas
the risk of malignancy index had low sensitivity. The
specificity of logistic regression models 1 and 2 was
significantly lower than that of subjective assessment
(47% and 50% v 80%, P<0.001 for both comparisons
among all patients; 64% and 63% v 85%, P<0.001 for
both comparisons among premenopausal patients;
21% and 30% v 73%, P<0.001 for both comparisons
among postmenopausal patients). The sensitivity of
the risk of malignancy index was significantly lower
than that of subjective assessment (50% v 89% among
all patients, P<0.001; 32% v 84%, P<0.001 among pre-
menopausal patients; 63% v 92%, P<0.001 among
postmenopausal patients).
If the simple rules were used in all tumours, the sen-
sitivity was 63% (340/542) and the specificity was 78%
(1083/1396). If the simple rules were used as a triage
test, and subjective assessment of ultrasound findings
was used for those masses for which the simple rules
yielded an inconclusive result (figure), the test perfor-
mance was as follows: sensitivity 91% (494/542) (63%
(340/542) by simple rules and 28% (154/542) by sub-
jective assessment), and specificity 93% (1294/1396)
(78% (1083/1396) by simple rules and 15% (211/
1396) by subjective assessment). This performance
was similar to that of using subjective assessment in
Table 3 | Sensitivity and specificity of subjective assessment,
logistic regression models 1 and 2, and risk of malignancy
index in cases in which simple rules yielded inconclusive
result, stratified by menopausal status
Sensitivity
(95% CI)
Specificity
(95% CI)
All cases
Total (n=437):
Subjective assessment 89 (83 to 93) 80 (75 to 84)
Logistic regression model 1 88 (83 to 92) 47 (41 to 53)
Logistic regression model 2 80 (74 to 86) 50 (44 to 56)
Premenopausal (n=227):
Subjective assessment 84 (74 to 91) 85 (78 to 90)
Logistic regression model 1 81 (71 to 89) 64 (56 to 71)
Logistic regression model 2 70 (58 to 79) 63 (55 to 70)
Postmenopausal (n=210):
Subjective assessment 92 (85 to 96) 73 (64 to 80)
Logistic regression model 1 93 (87 to 97) 21 (15 to 30)
Logistic regression model 2 87 (80 to 92) 30 (22 to 39)
Cases with CA 125 available
Total (n=357):
Subjective assessment 89 (83 to 93) 78 (72 to 83)
Logistic regression model 1 89 (83 to 93) 44 (38 to 51)
Logistic regression model 2 82 (75 to 87) 48 (42 to 55)
Risk of malignancy index 50 (42 to 58) 84 (78 to 88)
Premenopausal (n=182):
Subjective assessment 84 (73 to 91) 83 (75 to 88)
Logistic regression model 1 84 (73 to 91) 63 (54 to 71)
Logistic regression model 2 74 (62 to 83) 63 (54 to 71)
Risk of malignancy index 32 (22 to 45) 87 (79 to 92)
Postmenopausal (n=175):
Subjective assessment 92 (84 to 96) 71 (61 to 80)
Logistic regression model 1 93 (86 to 97) 20 (13 to 29)
Logistic regression model 2 88 (79 to 93) 28 (19 to 38)
Risk of malignancy index 63 (52 to 72) 80 (71 to 87)
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all tumours, which had a sensitivity of 90% (490/542)
(P=0.35) and a specificity of 93% (1294/1396) (P=1.0)
(table 4).
The simple rules yielded a conclusive result in most
benign tumours (81%, 1132/1396) and in most pri-
mary invasive tumours (74%, 275/373) but in only
half of the borderline tumours (50%, 56/111) (table 5).
The performance of the simple rules was poor for
abscesses, fibromas, and serous borderline stage I
tumours.
DISCUSSION
In this study, we have prospectively validated the abil-
ity of the IOTA simple ultrasound rules to discriminate
between benign and malignant adnexal masses. The
results of this study confirmed that when the rules
yielded a conclusive result, they reliably discriminated
between benign and malignant adnexal masses. They
did so just as well as did subjective assessment by an
experienced ultrasound examiner. The rules worked
well both on temporal validation in the centres where
they had been developed and on external validation in
the new centres. This confirms that the rules are gen-
eralisable. The test performance of a strategy in which
the simple ruleswere used as a triage test and subjective
assessment of ultrasonic findings was used as a second
stage test in thosemasses for which the rules yielded an
inconclusive result (sensitivity 91% and specificity
93%) was similar to that of using subjective assessment
by an experienced examiner in all tumours (sensitivity
90% and specificity 93%). Because few clinicians have
special skills in the ultrasound examination of ovarian
pathology, a reliable test that can be used effectively by
all ultrasound examiners is needed. The simple rules
have the potential to become that test.
Strengths and weaknesses
A strength of this study was its prospective and multi-
centre design. As the data were collected in different
countries with patients with different characteristics,
the simple rules are likely to prove applicable and to
perform well in other populations. Another strength is
the large number of patients studied with a detailed pre-
defined protocol with agreed terms, measurement tech-
nique, and definitions. We did both a temporal and an
external validation. Because the results were virtually
identical in the old and new centres, we can justify
reporting the results for the old and new centres
together to take advantage of a larger study population
and be able to estimate the measures of performance,
such as sensitivity and specificity,with greater precision.
A limitation of the study is that all the examinations
weredoneby experiencedultrasoundexaminers.Vali-
dation of the simple rules by less experienced exami-
ners is needed. The purpose is to use the rules for
triaging patients for referral to an examiner specialised
in gynaecological ultrasound.
Comparison with other studies
Previous studies on pre-operative characterisation of
adnexal masses as benign or malignant were mostly
small and single centre.7-9 12We have previously devel-
oped and tested the simple rules in a multicentre
study.5 However, Altman and colleagues wrote that
neither internal nor temporal validation examines the
generalisability of a model, for which using new data
collected from an appropriate patient population in a
different centre is necessary.22 This study contains the
first prospective temporal and external validation of
the simple rules, and the results of our external valida-
tion confirm the generalisability of these rules.
The main advantage of the simple rules is their sim-
plicity. The ultrasonic variables are straightforward to
obtain, and the rules are easier to use in clinical practice
than aremanymathematicalmodels. By using a simple
tick box system, a result can be produced rapidly with-
out the need for computer software. Moreover, con-
trary to when the risk of malignancy index is used, no
blood sample for a serum CA 125 is needed. The sim-
ple rules are therefore likely to be an ideal tool to help
less experienced ultrasound examiners to differentiate
between benign and malignant tumours. The disad-
vantage of the simple rules is that they yield an incon-
clusive result in about 25% of all tumours, whereas
mathematical models yield a useful result in all
masses.18 When using the simple rules, therefore, hav-
ing established appropriate referral patterns to a spe-
cialist in gynaecological ultrasound for cases in which
the simple rules yield an inconclusive result is impor-
tant. The risk of malignancy index or the two IOTA
logistic regressionmodels 1 and 2 are not good enough
for discrimination between benign and malignant
tumours when the simple rules yield an inconclusive
result. The rules seem to work less well for abscesses,
Table 4 | Sensitivity and specificity of strategy in which simple rules are used as triage test
and subjective assessment, logistic regression model 1 or 2, or risk of malignancy index is
used in tumours for which simple rules yield inconclusive result, and sensitivity and
specificity of using subjective assessment, logistic regression model 1 or 2, or risk of
malignancy index in all tumours
Sensitivity (95% CI) Specificity (95% CI)
Total (n=1938)
Simple rules + subjective assessment 91 (88 to 93) 93 (91 to 94)
Simple rules + logistic regression model 1 91 (88 to 93) 86 (84 to 88)
Simple rules + logistic regression model 2 88 (85 to 91) 87 (85 to 89)
Simple rules + inconclusive=“malignant”* 95 (92 to 96) 78 (75 to 80)
Subjective assessment 90 (88 to 93) 93 (91 to 94)
Logistic regression model 1 92 (90 to 94) 84 (82 to 86)
Logistic regression model 2 90 (88 to 93) 83 (81 to 85)
Cases with CA 125 available (n=1504)
Simple rules + subjective assessment 91 (88 to 93) 92 (90 to 93)
Simple rules + logistic regression model 1 91 (88 to 93) 85 (82 to 87)
Simple rules + logistic regression model 2 89 (86 to 91) 85 (83 to 88)
Simple rules + risk of malignancy index 79 (75 to 83) 93 (91 to 94)
Simple rules + inconclusive=“malignant”* 95 (92 to 96) 76 (73 to 78)
Subjective assessment 90 (87 to 92) 92 (90 to 93)
Logistic regression model 1 93 (90 to 95) 81 (79 to 84)
Logistic regression model 2 91 (88 to 93) 81 (79 to 83)
Risk of malignancy index 68 (63 to 72) 93 (91 to 94)
*Cases in which simple rules yielded inconclusive result are classified as malignant.
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fibromas, and stage I serous borderline tumours. These
conditions are also difficult to classify with subjective
assessment of ultrasonic findings.23 Future research
needs to determine the performance of the simple
rules when used by less experienced ultrasound exam-
iners and whether the use of the simple rules will
improve care of patients and reduce costs.
Conclusion
Because the simple rules offer a straightforward
approach to correctly characterise about 75% of
adnexal masses, their use should enable all sonogra-
phers and general gynaecologists to reliably distinguish
between benign and malignant adnexal masses in most
cases. Where the rules yield an inconclusive result, we
propose referring the patient for subjective assessment
of ultrasonic findings by an experienced ultrasound
examiner, because this provides themost accurate diag-
nosis. If we use the simple rules as a triage test and sub-
jective assessment by an experienced ultrasound
examiner as a second stage test in those masses for
which the simple rules yield an inconclusive result, we
obtain the same diagnostic performance as when sub-
jective assessment is used in all masses. In this way, the
use of the simple rules has the potential to improve the
management of women with adnexal masses.
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